We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DENTSPLY (XRAY) Q2 Earnings Top Estimates, Sales Up Y/Y
Read MoreHide Full Article
DENTSPLY SIRONA Inc (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products.
Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #2 (Buy) but that could change following its second quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 76 cents per share, which beat the Zacks Consensus Estimate by 6 cents and increased 4.1% on a year-over-year basis.
Revenues: DENTSPLY’s net sales surged 46.4% year over year to $1.02 billion, almost in line with the Zacks Consensus Estimate of $1.02 billion. Sales (excluding precious metals) of the combined businesses grew 3.4% at constant currency (cc) exchange rates.
Key Stats: Dental and Healthcare Consumables grew 3.4% at cc, while Technologies grew 3.3% in the quarter.
Major Factors: The quarterly upside was driven by robust performance in the Rest of World segment. Sales of the combined businesses grew 8.6% on a constant currency basis. Sales of the combined businesses in the U.S. grew 3.8% on a constant currency basis.
During the quarter, the company repurchased an additional $100 million of shares and paid $18 million in dividends.
Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this DENTSPLY earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DENTSPLY (XRAY) Q2 Earnings Top Estimates, Sales Up Y/Y
DENTSPLY SIRONA Inc (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products.
Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #2 (Buy) but that could change following its second quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 76 cents per share, which beat the Zacks Consensus Estimate by 6 cents and increased 4.1% on a year-over-year basis.
Revenues: DENTSPLY’s net sales surged 46.4% year over year to $1.02 billion, almost in line with the Zacks Consensus Estimate of $1.02 billion. Sales (excluding precious metals) of the combined businesses grew 3.4% at constant currency (cc) exchange rates.
Key Stats: Dental and Healthcare Consumables grew 3.4% at cc, while Technologies grew 3.3% in the quarter.
DENTSPLY SIRONA Price and EPS Surprise
DENTSPLY SIRONA Price and EPS Surprise | DENTSPLY SIRONA Quote
Major Factors: The quarterly upside was driven by robust performance in the Rest of World segment. Sales of the combined businesses grew 8.6% on a constant currency basis. Sales of the combined businesses in the U.S. grew 3.8% on a constant currency basis.
During the quarter, the company repurchased an additional $100 million of shares and paid $18 million in dividends.
Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this DENTSPLY earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>